Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Terminated 3Completed 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1Head & Neck 1

Conditions

Pancreatic Neoplasms 2Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Liver Neoplasms 1Head and Neck Neoplasms 1Fibrosis 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Enkephalin, Methionine × Clear all
NCT00109941 2018-09-06

OGF

Milton S. Hershey Medical Center

Phase 2 Completed
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00783172 2018-09-06

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Milton S. Hershey Medical Center

Phase 1 Terminated
4 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00706576 2017-08-02

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor

University of Missouri-Columbia

Phase 1 Completed
14 enrolled
Gastrointestinal

Fibrosis, Liver Neoplasms

NCT00982696 2014-09-30

Treatment of Advanced Head and Neck Cancer

Milton S. Hershey Medical Center

Phase 2 Terminated
5 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00255333 2007-05-14

INNO-105 in Patients With Solid Tumors

Innovive Pharmaceuticals

Phase 1 Terminated
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡